Results 71 to 80 of about 49,463 (304)

Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy

open access: yesJournal of Nanobiotechnology, 2021
Advantages of polymeric nanoparticles as drug delivery systems include controlled release, enhanced drug stability and bioavailability, and specific tissue targeting.
Sean Swetledge   +3 more
doaj   +1 more source

Migration pattern of silver eel (Anguilla anguilla, L.) in an obstructed river system. [PDF]

open access: yes, 2008
The downstream migration of European silver eels in the River Frémur was examined to determine the potential effects of the numerous migration barriers that exist on waterways in western France.
Acou   +62 more
core   +2 more sources

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

Topical Ocular Drug Delivery: The Impact of Permeation Enhancers

open access: yesPharmaceutics
Topical ophthalmic drug delivery targeting the posterior segment of the eye has become a key area of interest due to its non-invasive nature, safety, ease of application, patient compliance, and cost-effectiveness.
Gonçalo Santos   +4 more
doaj   +1 more source

A review of novel nanoformulations for treatment of dry eye disease and ocular surface inflammation [PDF]

open access: yesNanomedicine Journal
Dry eye disease (DED) is a multifactorial condition frequently encountered in ocular disorders. DED not only causes ocular discomfort but also leads to damage to the cornea and conjunctiva.
Alireza Nouralishahi   +6 more
doaj   +1 more source

Cataract Blindness: Socioeconomic Factors Associated with Treatment Barriers and High Blindness Rates for Women in Rural Regions of Andhra Pradesh [PDF]

open access: yes, 2018
Despite efforts of Vision 2020 in India, the 2001 Andhra Pradesh Eye Disease Study (APEDS) extrapolated that approximately 18.7 million blind people resided in India and projected an increase to 31.6 million blind people by 2020.
Kaur, Kiranpreet
core   +1 more source

Müller glia activation in response to inherited retinal degeneration is highly varied and disease-specific [PDF]

open access: yes, 2015
Despite different aetiologies, most inherited retinal disorders culminate in photoreceptor loss, which induces concomitant changes in the neural retina, one of the most striking being reactive gliosis by Müller cells.
Ali, RR   +6 more
core   +1 more source

Cognitive Status in People With Epilepsy in the Republic of Guinea: A Prospective, Case–Control Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective People with epilepsy (PWE) may experience cognitive deficits but fail to undergo formal evaluation. This study compares cognitive status between PWE and healthy controls in the West African Republic of Guinea. Methods A cross‐sectional, case–control study was conducted in sequential recruitment phases (July 2024–July 2025) at Ignace ...
Maya L. Mastick   +14 more
wiley   +1 more source

Impacts of Nanomedicines in Ocular Pharmacotherapy

open access: yesBioImpacts, 2011
Introduction: The integrity of the cells/tissues in anterior and/or posterior segments of the eye plays a crucial role in biofunctions of the vision.
Jaleh Barar, Ailar Nakhlband
doaj   +1 more source

Insights to Using Contact Lenses for Drug Delivery [PDF]

open access: yes, 2013
Phan, C.-M. (2013). Insights to Using Contact Lenses for Drug Delivery. Clinical & Experimental Pharmacology, 04(01). https://doi.org/10.4172/2161-1459.1000145There has been considerable interest in the potential application of contact lenses for ocular ...
Gao, Huayi   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy